2000
DOI: 10.1021/jo991375+
|View full text |Cite
|
Sign up to set email alerts
|

Structures of TMC-95A−D:  Novel Proteasome Inhibitors from Apiospora montagnei Sacc. TC 1093

Abstract: Four novel proteasome inhibitors, TMC-95A-D (1-4) have been isolated from the fermentation broth of Apiospora montagnei Sacc. TC 1093, isolated from a soil sample. All of the molecular formulas of 1-4 were established as C(33)H(38)N(6)O(10) by high-resolution FAB-MS. Their planar structures were determined on the basis of extensive analyses of 1D and 2D NMR, and degradation studies. Compounds 1-4 have the same planar structures to each other, and are unique highly modified cyclic peptides containing L-tyrosine… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
101
0
1

Year Published

2001
2001
2010
2010

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 266 publications
(104 citation statements)
references
References 15 publications
2
101
0
1
Order By: Relevance
“…235 While lactacystin and epoxomicin are the best known natural product inhibitors of the 20S proteasome, there have been other potent natural product proteasome inhibitors with novel structures. For example, in the course of proteasome inhibitor screening procedure, Kohno et al 257 found a series of TMC-95 (24) from the fermentation broth of Apiospora montagnei Sacc. TC 1093 (Fig.…”
Section: B Natural Product Proteasome Inhibitorsmentioning
confidence: 99%
“…235 While lactacystin and epoxomicin are the best known natural product inhibitors of the 20S proteasome, there have been other potent natural product proteasome inhibitors with novel structures. For example, in the course of proteasome inhibitor screening procedure, Kohno et al 257 found a series of TMC-95 (24) from the fermentation broth of Apiospora montagnei Sacc. TC 1093 (Fig.…”
Section: B Natural Product Proteasome Inhibitorsmentioning
confidence: 99%
“…These molecules are structurally characterized as novel cyclic peptides containing L-tyrosine, L-asparagine, highly oxidized L-tryptophan, (Z)-1-propenylamine (Z=benzyloxycarbonyl), and 3-methyl-2-oxopentanoic acid moieties. [30] Biological studies [29] showed that TMC-95A inhibited the CT-L, TL, and PGPH activities of 20S proteasome with IC 50 values (IC 50 =concentration required for 50% inhibition) of 5.4, 200, and 60nM, respectively. TMC-95B inhibited these activities to the same extent as TMC-95A, while TMC-95C and D were 20 -150 times weaker inhibitors.…”
Section: Introductionmentioning
confidence: 99%
“…3-Substituted 3-hydroxyoxindoles are encountered in a large variety of natural products with a wide spectrum of biological activities, such as convolutamydines, 1 donaxaridines, 2 maremycins, 3 dioxibrassinines, 4 celogentin K, 5 3'-hydroxy glucoisatisin, 6 and TMC-95A. 7 3-Alkenyl-and 3-aryl-substituted 3-hydroxyindoles, 8 and their derivatives 9 have been used in a number of recent pharmaceutical studies. The formation of quaternary carbon centers via addition of nucleophiles to ketone derivatives still constitutes a major challenge for synthetic chemistry.…”
Section: Introductionmentioning
confidence: 99%